{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:58:38Z","timestamp":1771462718319,"version":"3.50.1"},"reference-count":64,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:p>Among women with diabetes, the worst pregnancy outcome is seen in the subgroup of women with diabetic nephropathy. Development of severe preeclampsia that leads to early preterm delivery is frequent. Predictors and pathophysiological mechanisms for the development of preeclampsia among women with diabetes and observational studies that support antihypertension treatment for pregnant women with microalbuminuria or diabetic nephropathy preventing preeclampsia and early preterm delivery are presented here. Obtaining and maintaining strict glycemic control before and during pregnancy is paramount to prevent preterm delivery. The cornerstones of diabetes management are appropriate diet and insulin, although the risk of severe hypoglycemia always needs to be taken into account when tailoring a diabetes treatment plan. Pathophysiological mechanisms of the increased risk of hypoglycemia during pregnancy are explored, and studies evaluating the use of insulin analogs, insulin pumps, and continuous glucose monitoring to improve pregnancy outcomes and to reduce the risk of severe hypoglycemia in pregnant women with type 1 diabetes are reported. In addition to strict glycemic control, other factors involved in fetal overgrowth are explored, and restricting maternal gestational weight gain is a promising treatment area. The optimal carbohydrate content of the diet is discussed. In summary, the lessons learned from this clinical research are that glycemic control, gestational weight gain, and antihypertension treatment all are of importance for improving pregnancy outcomes in pregnant women with preexisting diabetes. An example of how to use app technology to share the recent evidence-based clinical recommendations for women with diabetes who are pregnant or planning pregnancy is given.<\/jats:p>","DOI":"10.2337\/dc16-1647","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T20:30:41Z","timestamp":1479846641000},"page":"2111-2117","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":23,"title":["Pregnancy Outcomes in Women With Diabetes\u2014Lessons Learned From Clinical Research: The 2015 Norbert Freinkel Award Lecture"],"prefix":"10.2337","volume":"39","author":[{"given":"Elisabeth R.","family":"Mathiesen","sequence":"first","affiliation":[{"name":"Center for Pregnant Women with Diabetes and Faculty of Health and Medical Sciences, Department of Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"key":"2022031220513516500_B1","unstructured":"Kitzmiller\u2008M\n          . Diabetic nephropathy and pregnancy. In Managing Preexisting Diabetes and Pregnancy. Kitzmiller\u2008JL, Jovanovic\u2008L, Brown\u2008F, Coustan\u2008D, Reader\u2008DM, Eds.Alexandria, VA, American Diabetes Association, 2008, p. 374\u2013386"},{"key":"2022031220513516500_B2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00125-014-3488-1","article-title":"Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011","volume":"58","author":"Klemetti","year":"2015","journal-title":"Diabetologia"},{"key":"2022031220513516500_B3","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.24.10.1739","article-title":"Pregnancy outcome in type 1 diabetic women with microalbuminuria","volume":"24","author":"Ekbom","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3109\/14767058.2013.794214","article-title":"Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning foetal and neonatal complications?","volume":"26","author":"Colstrup","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022031220513516500_B5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/diacare.25.3.554","article-title":"Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy","volume":"25","author":"Evers","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B6","volume-title":"Pregnancy in Women With Type 1 and Type 2 Diabetes in 2002-3","author":"Confidential Enquiry into Maternal and Child Health","year":"2005"},{"key":"2022031220513516500_B7","volume-title":"The Pregnant Diabetic and Her Newborn. Problems and Management","author":"Pedersen","year":"1967"},{"key":"2022031220513516500_B8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031220513516500_B9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","article-title":"Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria","volume":"303","author":"Mathiesen","year":"1991","journal-title":"BMJ"},{"key":"2022031220513516500_B10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.319.7201.24","article-title":"Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria","volume":"319","author":"Mathiesen","year":"1999","journal-title":"BMJ"},{"key":"2022031220513516500_B11","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2","author":"Abalos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031220513516500_B12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jdiacomp.2006.03.004","article-title":"Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes","volume":"21","author":"Clausen","year":"2007","journal-title":"J Diabetes Complications"},{"key":"2022031220513516500_B13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00125-011-2087-7","article-title":"A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes","volume":"54","author":"Ringholm","year":"2011","journal-title":"Diabetologia"},{"key":"2022031220513516500_B14","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.diabres.2011.06.007","article-title":"Atrial natriuretic peptide (ANP) in early pregnancy is associated with development of preeclampsia in type 1 diabetes","volume":"93","author":"Ringholm","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031220513516500_B15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00125-008-1182-x","article-title":"Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women","volume":"52","author":"Yu","year":"2009","journal-title":"Diabetologia"},{"key":"2022031220513516500_B16","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2337\/dc13-0944","article-title":"The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes","volume":"36","author":"Holmes","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/dc08-1526","article-title":"Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?","volume":"32","author":"Nielsen","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrendo.2012.154","article-title":"Managing type 1 diabetes mellitus in pregnancy--from planning to breastfeeding","volume":"8","author":"Ringholm","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"2022031220513516500_B19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11892-015-0705-3","article-title":"Diabetic nephropathy in women with preexisting diabetes: from pregnancy planning to breastfeeding","volume":"16","author":"Ringholm","year":"2016","journal-title":"Curr Diab Rep"},{"key":"2022031220513516500_B20","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2337\/dc13-1031","article-title":"Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome","volume":"36","author":"Damm","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/dc08-2061","article-title":"Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes","volume":"32","author":"Jensen","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jdiacomp.2007.03.008","article-title":"Elevated haemoglobin A1c in the third trimester predicts preterm delivery in type 1 diabetes","volume":"22","author":"Ekbom","year":"2008","journal-title":"J Diabet Complications"},{"key":"2022031220513516500_B23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bpobgyn.2010.11.001","article-title":"Stillbirth in diabetic pregnancies","volume":"25","author":"Mathiesen","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2022031220513516500_B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc07-1066","article-title":"Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control","volume":"31","author":"Nielsen","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B25","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.diabres.2013.09.011","article-title":"Severe hypoglycemia in pregnant women with type 2 diabetes-A relevant clinical problem","volume":"102","author":"Secher","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031220513516500_B26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0002-9378(92)91832-U","article-title":"Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus","volume":"166","author":"Diamond","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220513516500_B27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0029-7844(95)00495-5","article-title":"Counterregulatory hormonal responses to hypoglycemia during pregnancy","volume":"87","author":"Rosenn","year":"1996","journal-title":"Obstet Gynecol"},{"key":"2022031220513516500_B28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/00365513.2012.742926","article-title":"Impaired hormonal counterregulation to biochemical hypoglycaemia does not explain the high incidence of severe hypoglycaemia during pregnancy in women with type 1 diabetes","volume":"73","author":"Ringholm","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"key":"2022031220513516500_B29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dmrr.271","article-title":"Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences","volume":"18","author":"ter Braak","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031220513516500_B30","first-page":"E1014","article-title":"Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy","volume":"258","author":"Caufriez","year":"1990","journal-title":"Am J Physiol"},{"key":"2022031220513516500_B31","first-page":"E572","article-title":"Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies","volume":"265","author":"Caufriez","year":"1993","journal-title":"Am J Physiol"},{"key":"2022031220513516500_B32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1464-5491.2008.02495.x","article-title":"Lower levels of circulating IGF-I in type 1 diabetic women with frequent severe hypoglycaemia during pregnancy","volume":"25","author":"Ringholm Nielsen","year":"2008","journal-title":"Diabet Med"},{"key":"2022031220513516500_B33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diabres.2009.01.006","article-title":"Severe hypoglycaemia during pregnancy in women with type 1 diabetes: possible role of renin-angiotensin system activity?","volume":"84","author":"Nielsen","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031220513516500_B34","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(00)04405-6","article-title":"Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus","volume":"357","author":"Pedersen-Bjergaard","year":"2001","journal-title":"Lancet"},{"key":"2022031220513516500_B35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00125-002-0969-4","article-title":"Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes","volume":"46","author":"Pedersen-Bjergaard","year":"2003","journal-title":"Diabetologia"},{"key":"2022031220513516500_B36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B37","doi-asserted-by":"crossref","first-page":"186.e1","DOI":"10.1016\/j.ajog.2007.08.005","article-title":"Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects","volume":"198","author":"Hod","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220513516500_B38","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14767058.2013.799650","article-title":"A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes","volume":"27","author":"Hod","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022031220513516500_B40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diabres.2013.06.002","article-title":"The incidence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA1c levels and pregnancy outcomes in a routine care setting","volume":"101","author":"Ringholm","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031220513516500_B41","doi-asserted-by":"crossref","first-page":"e0155737","DOI":"10.1371\/journal.pone.0155737","article-title":"Prescribing of antidiabetic medicines before, during and after pregnancy: a study in seven European regions","volume":"11","author":"Charlton","year":"2016","journal-title":"PLoS One"},{"key":"2022031220513516500_B42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14767058.2013.837444","article-title":"Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes","volume":"27","author":"Mathiesen","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022031220513516500_B43","first-page":"337","article-title":"Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized controlled trial","volume":"25","author":"Murphy","year":"2008","journal-title":"BMJ"},{"key":"2022031220513516500_B44","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2337\/dc12-2360","article-title":"The effect of real-time continuous glucose monitoring in diabetic pregnancy - a randomized controlled trial","volume":"36","author":"Secher","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B45","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/dme.12246","article-title":"Real-time continuous glucose monitoring during labour and delivery in women with type 1 diabetes - observations from a randomized controlled trial","volume":"30","author":"Cordua","year":"2013","journal-title":"Diabet Med"},{"key":"2022031220513516500_B46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/dme.12383","article-title":"Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with type 1 diabetes - an observational study","volume":"31","author":"Secher","year":"2014","journal-title":"Diabet Med"},{"key":"2022031220513516500_B47","first-page":"244","article-title":"Prepregnancy body mass index and offspring birth weight in women with type 1 and type 2 diabetes. J Preg","volume":"3","author":"N\u00f8rgaard","year":"2016","journal-title":"Child Health"},{"key":"2022031220513516500_B48","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc16-0168","article-title":"Long-term Cognitive implications of intrauterine hyperglycemia in adolescent offspring of women with type 1 diabetes (the EPICOM Study)","volume":"39","author":"Bytoft","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B49","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00125-002-0958-7","article-title":"Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in the Netherlands","volume":"45","author":"Evers","year":"2002","journal-title":"Diabetologia"},{"key":"2022031220513516500_B50","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/aogs.12707","article-title":"Fetal sonographic characteristics associated with shoulder dystocia in pregnancies of women with type 1 diabetes","volume":"94","author":"Secher","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2022031220513516500_B51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/dc07-1596","article-title":"High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia","volume":"31","author":"Clausen","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B52","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00125-012-2721-z","article-title":"HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study","volume":"55","author":"Glinianaia","year":"2012","journal-title":"Diabetologia"},{"key":"2022031220513516500_B53","unstructured":"Institute of Medicine\n          . Weight Gain During Pregnancy: Reexamining the Guidelines [Internet], 2009. Available at http:\/\/www.nationalacademies.org\/hmd\/Reports\/2009\/Weight-Gain-During-Pregnancy-Reexamining-the-Guidelines.aspx. Accessed 29 July 2016"},{"key":"2022031220513516500_B54","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2337\/diacare.28.9.2118","article-title":"Gestational weight gain and pregnancy outcomes in 481 obese glucose-tolerant women","volume":"28","author":"Jensen","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B55","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc12-1232","article-title":"Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes","volume":"36","author":"Asbj\u00f6rnsd\u00f3ttir","year":"2013","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B56","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/dme.12558","article-title":"Fetal growth in relation to gestational weight gain in women with type 2 diabetes: an observational study","volume":"31","author":"Parellada","year":"2014","journal-title":"Diabet Med"},{"key":"2022031220513516500_B57","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc14-0896","article-title":"Higher gestational weight gain is associated with increasing offspring birth weight independent of maternal glycemic control in women with type 1 diabetes","volume":"37","author":"Secher","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031220513516500_B58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/jc.2013-2684","article-title":"ATLANTIC-DIP: excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus","volume":"99","author":"Egan","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031220513516500_B59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14767058.2014.906577","article-title":"Dietary advices on carbohydrate intake for pregnant women with type 1 diabetes","volume":"28","author":"Roskj\u00e6r","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022031220513516500_B60","volume-title":"Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids (Macronutrients)","author":"Institute of Medicine","year":"2005"},{"key":"2022031220513516500_B61","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJM199109263251303","article-title":"Correlations between antepartum maternal metabolism and child intelligence","volume":"325","author":"Rizzo","year":"1991","journal-title":"N Engl J Med"},{"key":"2022031220513516500_B62","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/dme.12446","article-title":"Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review","volume":"31","author":"Schmidt","year":"2014","journal-title":"Diabet Med"},{"key":"2022031220513516500_B63","unstructured":"Juul HM. Pregnant with Diabetes [Internet]. Available at www.pregnantwithdiabetes.com. Accessed 29 July 2016"},{"key":"2022031220513516500_B64","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc15-0360","article-title":"Results from a European multicenter randomized trial of physical activity and\/or healthy eating to reduce the risk of gestational diabetes mellitus: the DALI lifestyle pilot","volume":"38","author":"Simmons","year":"2015","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc16-1647","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/12\/2111\/545628\/dc161647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/12\/2111\/545628\/dc161647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:55:13Z","timestamp":1647125713000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/12\/2111\/31638\/Pregnancy-Outcomes-in-Women-With-Diabetes-Lessons"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,10]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,11,10]]},"published-print":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc16-1647","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,10]]}}}